SAN ANTONIO — The first-in-human trial of ultra-high-dose-rate radiotherapy, known as FLASH therapy, found not only that it was feasible for treating bone metastases, but also that it offered pain ...
Flash ultra-high dose rate therapy enabled by Varian proton and planning technologies Collaboration between Varian and leading institutions drives progress toward next-generation cancer treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results